Cimpress plc (NASDAQ:CMPR – Get Free Report) fell 5.6% during mid-day trading on Friday . The company traded as low as $77.25 and last traded at $77.48. 32,515 shares traded hands during trading, a decline of 78% from the average session volume of 150,292 shares. The stock had previously closed at $82.05.
Wall Street Analyst Weigh In
CMPR has been the topic of several recent research reports. StockNews.com cut Cimpress from a “strong-buy” rating to a “buy” rating in a research report on Friday, November 8th. Truist Financial dropped their target price on Cimpress from $120.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, November 1st. Finally, Barrington Research increased their price target on Cimpress from $113.00 to $119.00 and gave the stock an “outperform” rating in a report on Tuesday, August 27th.
Get Our Latest Analysis on Cimpress
Cimpress Stock Down 4.0 %
Cimpress (NASDAQ:CMPR – Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The business services provider reported ($0.50) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.80). Cimpress had a net margin of 4.69% and a negative return on equity of 27.15%. The company had revenue of $804.97 million during the quarter, compared to analysts’ expectations of $800.51 million. During the same quarter in the prior year, the business earned $0.17 EPS. On average, analysts expect that Cimpress plc will post 4.27 EPS for the current year.
Institutional Trading of Cimpress
Several large investors have recently bought and sold shares of CMPR. Janus Henderson Group PLC boosted its position in shares of Cimpress by 5.2% in the 3rd quarter. Janus Henderson Group PLC now owns 2,847,327 shares of the business services provider’s stock worth $233,253,000 after buying an additional 140,899 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Cimpress by 0.9% during the 2nd quarter. Dimensional Fund Advisors LP now owns 512,613 shares of the business services provider’s stock worth $44,909,000 after purchasing an additional 4,441 shares in the last quarter. Diamond Hill Capital Management Inc. raised its position in shares of Cimpress by 6.3% during the 3rd quarter. Diamond Hill Capital Management Inc. now owns 450,253 shares of the business services provider’s stock worth $36,885,000 after purchasing an additional 26,727 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Cimpress by 11.0% in the second quarter. Acadian Asset Management LLC now owns 397,170 shares of the business services provider’s stock worth $34,776,000 after acquiring an additional 39,438 shares during the last quarter. Finally, Hantz Financial Services Inc. raised its stake in Cimpress by 0.5% in the 3rd quarter. Hantz Financial Services Inc. now owns 145,703 shares of the business services provider’s stock valued at $11,936,000 after purchasing an additional 785 shares during the last quarter. Institutional investors and hedge funds own 77.64% of the company’s stock.
About Cimpress
Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. The company operates through five segments: Vista, PrintBrothers, The Print Group, National Pen, and All Other Businesses. It offers printed and digital marketing products; internet-based canvas-print wall décor, business signage, and other printed products; business cards; and marketing materials, such as flyers and postcards, digital and marketing services, writing instruments, decorated apparel, promotional products and gifts, packaging, design services, textiles, and magazines and catalogs.
Recommended Stories
- Five stocks we like better than Cimpress
- Business Services Stocks Investing
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Using the MarketBeat Dividend Yield Calculator
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What Are Dividends? Buy the Best Dividend Stocks
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Cimpress Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cimpress and related companies with MarketBeat.com's FREE daily email newsletter.